MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-30-2022
Genetic Technologies Limited P/CF Ratio 2011-2025 | GENE
Annual P/CF Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.63 K | -2.71 K | -2.91 K | -1.91 | -3.53 | -1.83 | -3.23 | -2.47 | -1.58 | -5.3 | -7.43 | 38.9 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.9 | -2.91 K | -603 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
271 | $ 18.94 | -0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 20.99 | 1.77 % | $ 226 M |  China |
 |
Co-Diagnostics
CODX
|
-1.58 | $ 0.17 | -7.36 % | $ 4.99 M | USA |
 |
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
10.9 | $ 39.2 | -0.28 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
22.7 | $ 229.76 | -0.39 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.43 | $ 10.67 | -0.28 % | $ 303 M | Israel |
 |
BioNano Genomics
BNGO
|
-0.0515 | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
44.3 | $ 101.87 | -0.03 % | $ 18.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
65.2 | $ 66.72 | -0.51 % | $ 25.8 B | USA |
 |
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
22.2 | $ 26.24 | -0.94 % | $ 793 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | USA |
 |
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-28.3 | $ 18.93 | -0.73 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-4.78 | $ 99.81 | -0.11 % | $ 3.94 B | USA |
 |
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-0.00965 | $ 3.15 | 1.11 % | $ 100 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
13.1 | $ 226.38 | -0.58 % | $ 41 B | USA |
 |
Guardant Health
GH
|
-24.4 | $ 102.5 | 1.89 % | $ 12.6 B | USA |
 |
NeoGenomics
NEO
|
217 | $ 12.06 | -1.43 % | $ 1.53 B | USA |
 |
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-112 | $ 6.16 | -0.24 % | $ 558 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.297 | $ 4.6 | -3.36 % | $ 2.47 M | USA |
 |
Neogen Corporation
NEOG
|
17.5 | $ 7.05 | -0.07 % | $ 1.53 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.18 | -0.73 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-5.62 | $ 8.09 | 1.51 % | $ 479 M | USA |
 |
Quidel Corporation
QDEL
|
18.7 | $ 28.89 | -1.4 % | $ 1.22 B | USA |
 |
National Research Corporation
NRC
|
26.5 | $ 18.6 | -0.29 % | $ 456 M | USA |
 |
RadNet
RDNT
|
15.8 | $ 71.29 | -0.28 % | $ 5.21 B | USA |
 |
Illumina
ILMN
|
19.6 | $ 131.43 | -1.0 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
11.6 | $ 200.55 | -0.71 % | $ 10.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
-28.3 | $ 45.83 | -0.99 % | $ 1.84 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
14.3 | $ 174.36 | -0.64 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-1.89 | $ 6.73 | 0.07 % | $ 873 M | USA |
 |
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.3 | $ 251.76 | -0.52 % | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
12.9 | $ 182.23 | -0.42 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
40.5 | $ 679.89 | -0.36 % | $ 56.1 B | USA |
 |
Lantheus Holdings
LNTH
|
11.9 | $ 66.93 | -0.34 % | $ 4.63 B | USA |